Nurse Anesthetist - CR in New Rochelle, NY Accepting Medicare

9 Nurse Anesthetist - CR nurses found. Showing 1 - 9

Mrs. Florence E. Attaway, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 10 Commerce Dr, New Rochelle, NY 10801 Phone: 914-637-3510    Fax: 914-819-0061

Mrs. Mary Ann Schmidt, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 10 Commerce Dr, New Rochelle, NY 10801 Phone: 914-637-3510    Fax: 914-819-0061

Mrs. Ellen P. Hansen, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 10 Commerce Dr, New Rochelle, NY 10801 Phone: 914-637-3510    Fax: 914-819-0061

Mrs. Lisa M. Felderman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10 Commerce Dr, New Rochelle, NY 10801 Phone: 914-637-3510    Fax: 914-819-0061

Mr. Rene A. Bouquet, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10 Commerce Dr, New Rochelle, NY 10801 Phone: 914-637-3510    Fax: 914-819-0061

Summer Dawn Lofton - Derrick, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: May Accept Medicare Assignments Practice Location: 87 Old Boston Post Rd, New Rochelle, NY 10801 Phone: 972-998-5402

Ms. Sylvia H. Dickens, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 10 Commerce Dr, New Rochelle, NY 10801 Phone: 914-637-3510    Fax: 914-819-0061

Mr. Paul E. Mercier, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 10 Commerce Dr, New Rochelle, NY 10801 Phone: 914-637-3510    Fax: 914-819-0061

Ms. Maria Lamanna, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10 Commerce Dr, New Rochelle, NY 10801 Phone: 914-637-3510    Fax: 914-819-0061

News Archive

FDA warns against use of high-strength hydrogen peroxide to treat serious diseases

The Food and Drug Administration in the U.S. has issued a warning against drinking or injecting high-strength hydrogen peroxide products to treat serious diseases such as AIDS.

Moores Cancer Center files IND application for topical NexACT-based formulation

Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).

Phase 1 clinical trial of iCo-007 demonstrates positive safety profile

iCo Therapeutics Inc. - iCo Therapeutics ("iCo") is pleased to announce that its Phase 1 clinical trial of iCo-007, having enrolled all patients in four cohorts of increasing concentration (110ug, 350ug, 700ug, 1000ug), has to date demonstrated a positive safety profile.

Most of the world unprepared for next epidemic or pandemic, GHS Index shows

No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.

Read more Medical News

› Verified 6 days ago